Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 145,493 | 128,853 | 181,468 | 34,597 | -36,944 |
| Depreciation Amortization | 22,551 | 23,918 | 24,616 | 21,078 | 12,649 |
| Income taxes - deferred | -29,298 | -13,419 | -85,943 | N/A | N/A |
| Accounts receivable | -8,893 | -19,400 | -19,897 | -12,667 | -17,922 |
| Accounts payable and accrued liabilities | -5,384 | 8,949 | 2,785 | -1,555 | -3,804 |
| Other Working Capital | -7,321 | 35,035 | -4,106 | 631 | -11,628 |
| Other Operating Activity | 102,673 | 55,451 | 45,543 | 56,473 | 54,664 |
| Operating Cash Flow | $219,821 | $219,387 | $144,466 | $98,557 | $-2,985 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,153 | -312 | -172 | -298 | -2 |
| Net Acquisitions | -33,069 | -36,967 | N/A | N/A | N/A |
| Purchase Of Investment | -105,289 | -127,469 | -110,729 | N/A | N/A |
| Sale Of Investment | 98,527 | 118,309 | 9,069 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -100,000 | -2,000 |
| Other Investing Activity | -26,500 | 0 | -40,000 | -100,000 | -2,000 |
| Investing Cash Flow | $-67,484 | $-46,439 | $-141,832 | $-100,298 | $-2,002 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 200,000 | N/A | 200,000 | 200,000 |
| Debt Repayment | -15,000 | -201,250 | -2,000 | -200,500 | -102,538 |
| Common Stock Issued | 6,501 | 5,055 | 8,841 | 39,371 | 147,927 |
| Common Stock Repurchased | N/A | -100,000 | N/A | N/A | -167 |
| Other Financing Activity | -2,497 | -9,357 | 0 | -31,452 | -36,061 |
| Financing Cash Flow | $-10,996 | $-105,552 | $6,841 | $7,419 | $209,161 |
| Beginning Cash Position | 311,930 | 244,534 | 235,059 | 229,381 | 25,207 |
| End Cash Position | 453,271 | 311,930 | 244,534 | 235,059 | 229,381 |
| Net Cash Flow | $141,341 | $67,396 | $9,475 | $5,678 | $204,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | 219,821 | 219,387 | 144,466 | 98,557 | -2,985 |
| Capital Expenditure | -1,153 | -312 | -172 | -298 | -2 |
| Free Cash Flow | 218,668 | 219,075 | 144,294 | 98,259 | -2,987 |